ARTICLE | Company News
Biovail gets generic approval
March 13, 2000 8:00 AM UTC
Biovail (BVF; TSE:BVF) received FDA marketing approval for its 30 mg generic Adalat nifedipine to treat hypertension. The product, in-licensed from Elan (ELN) in October 1999, will be marketed in the ...